<DOC>
	<DOCNO>NCT00098137</DOCNO>
	<brief_summary>Hypothesis : Blocking angiotensin ( AT ) II type 1 receptor ( Olmesartan ) reduce incidence episode atrial fibrillation patient paroxysmal atrial fibrillation 12 month 25 % compare standard medication without angiotensin II type 1 receptor . A total 422 subject include two study group . The treatment arm receive 40mg Olmesartan per day , remain patient receive placebo . Follow-up 12 month . Daily Tele-ECG recording determine cardiac rhythm asymptomatic episode atrial fibrillation ( AF ) every day . Concomitant therapy AV-nodal blocking drug allow study . In case severe AF-induced symptom , antiarrhythmic `` recovery medication '' ( amiodarone ) allow follow-up .</brief_summary>
	<brief_title>Trial Investigate Efficacy Olmesartan Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>Double-blind , central randomization , two treatment group , stratify beta-blocker use . 211 patient treatment arm .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<criteria>Documented paroxysmal atrial fibrillation : ECG documentation atrial fibrillation least one ECG record last 2 month prior randomization plus additional ECG record sinus rhythm least 12 hour mention ECG documentation . Age â‰¥ 18 Patient inform orally write Written informed consent patient Strong clinical evidence therapy AT II/ACE inhibitor AT II/ACE inhibitor therapy within last month Therapy antiarrhythmic agent class I class III within last month , therapy amiodarone within last 3 month Direct current ( DC ) cardioversion within last 3 month Symptomatic bradycardia Implanted pacemaker implant cardioverter/defibrillator antitachycardiac algorithm use Cardiac surgery cardiac catheter ablation within last 3 month Typical angina pectoris symptom rest exercise Known coronary artery disease indication intervention Valvular disease &gt; II degree Left ventricular ejection fraction &lt; 40 % Diastolic blood pressure &gt; 110mm Hg rest Symptomatic arterial hypotension Known renal artery stenosis Serum creatinine &gt; 1.8 mval/l Relevant hepatic pulmonary disorder Hyperthyroidism manifest clinically laboratory Known drug intolerance AT II inhibitor Females pregnant breast feeding Females childbearing potential use scientifically accept method contraception Participation clinical trial within last 30 day Drug addiction chronic alcohol abuse Legal incapacity , circumstance would prevent patient understanding aim , nature extent clinical study Evidence uncooperative attitude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>angiotensin II</keyword>
	<keyword>angiotensin receptor antagonist</keyword>
	<keyword>drug</keyword>
	<keyword>control clinical trial</keyword>
</DOC>